Navigation Links
Ensuring Pharmaceutical Organizations are Effectively Organizing and Deploying Medical Science Liaisons across Diverse Customer Groups
Date:2/8/2013

CHAPEL HILL, N.C., Feb. 8, 2013 /PRNewswire/ -- Medical Science Liaisons play a critical role in developing the relationships that drive success in the pharmaceutical sector. The importance of MSLs is demonstrated by how their customer groups have expanded and now includes regional thought leaders, important clinical investigators, local opinion leaders, payers and government thought leaders.

As the role of Medical Science Liaisons expands across a diverse set of customers in the pharmaceutical sector, organizations are finding it increasingly challenging for their MSL groups to deliver exceptional services.

To help biopharmaceutical companies better deal with the expanding role of MSL groups and the challenging environment they face, research and consulting firm Best Practices, LLC has conducted a comprehensive research study of the structure, management and services that are hallmarks of successful MSL groups.

"Medical Science Liaison Services Excellence: Generating Value for Diverse Customer Groups" explores how biopharma companies deliver exceptional MSL Services to various customer groups and stakeholders in an increasingly challenging business environment.

Topics addressed in the study included:

  • Determine the structure and overall organization of Medical Science Liaisons (MSLs) Services, including geographic span, oversight responsibility and services provided to various customer segments.
  • Explore the methods used by MSLs to serve stakeholders and build those stakeholder relationships.
  • Identify roles, responsibilities and service levels provided to Key Opinion Leaders (KOLs).
  • Explore the ways through which MSLs provide services to KOLs. Determine frequency of services during pre- and post-approval stages.
  • Identify relationship development and management process used by MSLs for internal and external users.
  • Determine changing trends in the field of MSL management.
  • Identify risk factors involved in serving KOLs
  • Explore use of new technology for providing services.

In addition, the study reviews concerns about compliance and legal limitations that are forcing companies to re-examine how their MSLs and internal medical staff can work together to build strong relationships with key customer groups and decision-makers.

This study is based on research and information provided by 35 pharmaceutical and medical device executives from 30 companies. The 145-page report provides two segments: the total benchmark class and U.S. only. 

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http://www3.best-in-class.com/rr1203.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Dec. 7, 2016  Organovo Holdings, Inc. (NASDAQ: ... company focused on delivering scientific and medical breakthroughs ... Chairman and Chief Executive Officer Keith Murphy ... Wednesday, December 14, 2016 at 1:00 p.m. Eastern ... not yet familiar with the Company, an informational ...
(Date:12/7/2016)... , December 7, 2016 ... reach a value of USD 3.9 billion by ... View Research, Inc. The growth of the market ... and continuous technological advancements by the market players. ... due to increasing donation, rising awareness about transfusion-transmitted ...
(Date:12/6/2016)... 2016 Diabetes & Obesity Drug Development Pipeline ... disease cluster is currently dominated by therapeutics indicated for ... mellitus (T2DM), and the majority of the pipeline, in ... attributable to these indications. While products indicated for obesity ... are a large number of these products in the ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an informative and ... one hour a week showing of hands. “The Road To Restoration” is the creation ... are familiar with the brass ring that you could reach out for, and grab, ...
(Date:12/7/2016)... ... December 07, 2016 , ... “Walking With God: Inspirational Lessons from My Life's ... reader to be aware of God's direction in their lives. “Walking With God: Inspirational ... teacher and active church leader. , Sanford says, “I enjoy sharing the ...
(Date:12/7/2016)... 3, 2016) , ... (PRWEB) December 07, 2016 ... ... patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, was awarded a ... Mexico with a patient engagement program. New Mexico has more people with cavernous ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... present at the International Probiotic Association’s Washington DC workshop on November 2nd. The ... engage in dialog regarding probiotic dietary supplement regulations. , Dr. Leyer spoke ...
(Date:12/7/2016)... ... December 07, 2016 , ... "Hacking into my medical record ... him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in the ... Wyston Books, Inc. These novels narrate the lives of a poor teenager ...
Breaking Medicine News(10 mins):